NRC Health: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Oct. 27, 2026, NRC Health (NASDAQ:NRC) reported an 11% increase in total recurring contract value, or TRCV, to $151.9 million. That expansion signals steady customer demand for experience management tools even as implementation costs compress near-term profits.

Three things management said stand out.

1. Contract Value Growth Outpaces Revenue as System Implementations Scale

Management held adjusted EBITDA, or earnings before interest, taxes, depreciation, and amortization, margins steady at 27% while funding implementation capacity for major health system contracts. Upfront investments in delivery teams will weigh on short-term profits before contract expansion fuels revenue in the second half of the year.

As planned, we maintain margins, while building the delivery capacity required for the first phase of this multiyear engagement. We continue to expect margin expansion in the second half of the year as revenue increasingly reflects the TRCV growth we have generated.
-- Trent Green, Chief Executive Officer

2. Single-Product Customers Offer a Massive Expansion Opportunity

A vast majority of the company's healthcare clients buy only one solution line, leaving substantial room for contract expansion. Management restructured its sales organization around buyer behavior to sell integrated packages across patient experience measurement, strategic governance, and real-time operational improvement tools.

70% of our customers only buy 1 product from NRC today or roughly I think it might be I think it might be 71% of our customers or something buy only 1 product.
-- Trent Green, Chief Executive Officer

3. Sales Pipeline Grew 60% Amid Competitor Merger Disruption

Industry consolidation created market noise as rivals Qualtrics and Press Ganey merged, prompting some healthcare system buyers to pause ongoing vendor evaluations. NRC Health capitalized on the market uncertainty by boosting sales meeting activity 35% year over year and expanding its deal pipeline.

Our pipeline generation has been strong. Our pipeline is up 60% higher than it was the same quarter last year.
-- Trent Green, Chief Executive Officer

Looking Ahead

Customer meeting activity is accelerating as health systems seek operational stability, and NRC Health's deep domain focus creates a distinct edge. Decades of interconnected patient and employee data provide a structural advantage that generic software models can't match.

No other organization can offer our laser focus this breadth depth, and longitudinal history of healthcare experience data.
-- Trent Green, Chief Executive Officer

Execution hinges on converting recent contract wins into profitable recurring revenue while deploying cash prudently across internal research, strategic M&A, or mergers and acquisitions, and share buybacks.

We will continue to evaluate the relative attractiveness of internal investment, strategic M&A and share repurchases with the goal of compounding free cash flow per share over time.
-- Shane R. Harrison, Chief Financial Officer

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.